Page last updated: 2024-09-05
aluminum hydroxide, magnesium hydroxide, drug combination and raloxifene hydrochloride
aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with raloxifene hydrochloride in 1 studies
Compound Research Comparison
Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
---|---|---|---|---|---|
253 | 100 | 17 | 2,818 | 481 | 810 |
Protein Interaction Comparison
Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | raloxifene hydrochloride (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.0053 | |
Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Das, P; Duggal, S; Kumar, M; Maiti, P; Mishra, DP; Rana, D; Senapati, S; Shripathi, T; Thakur, R; Verma, SP | 1 |
Other Studies
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and raloxifene hydrochloride
Article | Year |
---|---|
Layered double hydroxides as effective carrier for anticancer drugs and tailoring of release rate through interlayer anions.
Topics: Aluminum Hydroxide; Animals; Anions; Antineoplastic Agents; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Liberation; Female; HeLa Cells; Humans; Magnesium Hydroxide; Male; Mice; Mice, Inbred BALB C; Particle Size; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley | 2016 |